Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer

International Journal of Gynecological Cancer

Volumn 26, Issue 9, 2016, Pages 1594-1600

  Ataseven, Beyhan ^a   Du Bois, Andreas ^a   Harter, Philipp ^a   Prader, Sonia ^a   Grimm, Christoph ^a,b   Kurzeder, Christian ^a   Schneider, Stephanie ^a   Heikaus, Sebastian ^a   Kahl, Anett ^a   Traut, Alexander ^a   Heitz, Florian ^a  

^a KLINIKEN ESSEN MITTE   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abdominal wall metastasis; Epithelial ovarian cancer; Overall survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL WALL; ABDOMINAL WALL METASTASIS; ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; METASTASIS; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; ADULT; EPIDEMIOLOGY; GERMANY; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ABDOMINAL WALL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84994669225     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000826     Document Type: Article

References (24)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108
2. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the fallopian tube. FIGO 26th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S145-S160
3. Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecology Obstet. 2014;124:1-5
4. Ndofor BT, Soliman PT, Schmeler KM, et al. Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer. 2011;21:936-940
5. van den Tillaart SA, Schoneveld A, Peters IT, et al. Abdominal scar recurrences of cervical cancer: incidence and characteristics: a caseYcontrol study. Int J Gynecol Cancer. 2010;20:1031-1040
6. Zivanovic O, Sonoda Y, Diaz JP, et al. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol. 2008;111: 431-437
7. Heitz F, Ognjenovic D, Harter P, et al. Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications. Int J Gynecol Cancer. 2010;20:41-46
8. Kruitwagen RF, Swinkels BM, Keyser KG, et al. Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer. Gynecol Oncol. 1996;60:233-237
9. Vergote I, Marquette S, Amant F, et al. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer. 2005;15:776-779
10. Nunez MF, Sardi A, Jimenez W, et al. Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:1267-1273
11. Maker AV, Butte JM, Oxenberg J, et al. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol. 2012;19:409-417
12. Harter P, Muallem ZM, Buhrmann C, et al. Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer. Gynecol Oncol. 2011; 121:615-619
13. Bois A, Quinn M, Thigpen T, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16(Suppl 8):viii7-viii12
14. Stuart GC, Kitchener H, Bacon M, et al. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer. 2011; 21:750-755
15. du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d' Investigateurs Nationaux Pour les Etudes des Cancers de l' Ovaire (GINECO). Cancer. 2009;115:1234-1244
16. Riester M, Wei W, Waldron L, et al. Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. J Natl Cancer Inst. 2014;106. pii: dju048
17. Tucker SL, Gharpure K, Herbrich SM, et al. Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res. 2014;20: 3280-3288
18. Liu Z, Beach JA, Agadjanian H, et al. Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. Gynecol Oncol. 2015;139:394-400
19. Ataseven B, Grimm C, Harter P, et al. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecol Oncol. 2016;140: 215-220
20. Liu QD, Chen JZ, Xu XY, et al. Incidence of port-site metastasis after undergoing robotic surgery for biliary malignancies. World J Gastroenterol. 2012;18:5695-5701
21. Cava A, Roman J, Gonzalez Quintela A, et al. Subcutaneous metastasis following laparoscopy in gastric adenocarcinoma. Eur J Surg Oncol. 1990;16:63-67
22. van Dam PA, DeCloedt J, TjalmaWA, et al. Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol. 1999; 181:536-541
23. Rindos N, Curry CL, Tabbarah R, et al. Port-site metastases after robotic surgery for gynecologic malignancy. JSLS. 2014;18:66-70
24. Odicino F, Pecorelli S, Zigliani L, et al. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008;101: 205-210